These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 19847158)
1. Linking an insect enzyme to hypertension: angiotensin II-epoxide hydrolase interactions. Ai D; Shyy JY; Zhu Y Kidney Int; 2010 Jan; 77(2):88-92. PubMed ID: 19847158 [TBL] [Abstract][Full Text] [Related]
2. Deletion of soluble epoxide hydrolase attenuates cardiac hypertrophy via down-regulation of cardiac fibroblasts-derived fibroblast growth factor-2. Zhang H; Wang T; Zhang K; Liu Y; Huang F; Zhu X; Liu Y; Wang MH; Tang W; Wang J; Huang H Crit Care Med; 2014 May; 42(5):e345-54. PubMed ID: 24448199 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo. Ai D; Fu Y; Guo D; Tanaka H; Wang N; Tang C; Hammock BD; Shyy JY; Zhu Y Proc Natl Acad Sci U S A; 2007 May; 104(21):9018-23. PubMed ID: 17495027 [TBL] [Abstract][Full Text] [Related]
4. Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension. Jung O; Brandes RP; Kim IH; Schweda F; Schmidt R; Hammock BD; Busse R; Fleming I Hypertension; 2005 Apr; 45(4):759-65. PubMed ID: 15699457 [TBL] [Abstract][Full Text] [Related]
5. Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy. Ai D; Pang W; Li N; Xu M; Jones PD; Yang J; Zhang Y; Chiamvimonvat N; Shyy JY; Hammock BD; Zhu Y Proc Natl Acad Sci U S A; 2009 Jan; 106(2):564-9. PubMed ID: 19126686 [TBL] [Abstract][Full Text] [Related]
6. Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage. Zhao X; Yamamoto T; Newman JW; Kim IH; Watanabe T; Hammock BD; Stewart J; Pollock JS; Pollock DM; Imig JD J Am Soc Nephrol; 2004 May; 15(5):1244-53. PubMed ID: 15100364 [TBL] [Abstract][Full Text] [Related]
7. Different mechanisms of acute versus long-term antihypertensive effects of soluble epoxide hydrolase inhibition: studies in Cyp1a1-Ren-2 transgenic rats. Sporková A; Jíchová S; Husková Z; Kopkan L; Nishiyama A; Hwang SH; Hammock BD; Imig JD; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Cervenka L Clin Exp Pharmacol Physiol; 2014 Dec; 41(12):1003-13. PubMed ID: 25224811 [TBL] [Abstract][Full Text] [Related]
17. Soluble epoxide hydrolase: A potential target for metabolic diseases. He J; Wang C; Zhu Y; Ai D J Diabetes; 2016 May; 8(3):305-13. PubMed ID: 26621325 [TBL] [Abstract][Full Text] [Related]